Magnetic doxorubicin liposome nanoparticles
Magnetic doxorubicin liposome nanoparticles
Magnetic doxorubicin liposome nanoparticles from ruixi.Magnetic adriamycin nanoparticles have good magnetic field response in vitro and in vivo. The drug was given by magnetic nano liposomes and magnetic field, and adriamycin could be effectively gathered in the target area, which significantly increased the concentration of adriamycin in the target site and decreased the drug concentration in heart and kidney tissue. As an effective carrier of adriamycin, the magnetic nano liposome and magnetic field administration method is expected to be a new approach for tumor targeted treatment. As a new carrier of chemotherapeutic drugs, magnetic nanoliposomes can effectively improve the concentration of chemotherapeutic drugs in tumor tissues, reduce the toxic and side effects of chemotherapy drugs and significantly inhibit the growth of tumor tissue.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >95% |
Solubility | Organic solvents |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |